Cargando…
Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256991/ https://www.ncbi.nlm.nih.gov/pubmed/37303815 http://dx.doi.org/10.1002/mco2.307 |
_version_ | 1785057224427569152 |
---|---|
author | Deng, Guangtong Zhou, Qian Meng, Yu Sun, Huiyan Du, Songtao Liu, Yihuang Zeng, Furong |
author_facet | Deng, Guangtong Zhou, Qian Meng, Yu Sun, Huiyan Du, Songtao Liu, Yihuang Zeng, Furong |
author_sort | Deng, Guangtong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10256991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102569912023-06-11 Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis Deng, Guangtong Zhou, Qian Meng, Yu Sun, Huiyan Du, Songtao Liu, Yihuang Zeng, Furong MedComm (2020) Letter John Wiley and Sons Inc. 2023-06-09 /pmc/articles/PMC10256991/ /pubmed/37303815 http://dx.doi.org/10.1002/mco2.307 Text en © 2023 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter Deng, Guangtong Zhou, Qian Meng, Yu Sun, Huiyan Du, Songtao Liu, Yihuang Zeng, Furong Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title | Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title_full | Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title_fullStr | Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title_full_unstemmed | Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title_short | Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis |
title_sort | risk and outcomes of breakthrough covid‐19 infections in vaccinated immunocompromised patients: a meta‐analysis |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256991/ https://www.ncbi.nlm.nih.gov/pubmed/37303815 http://dx.doi.org/10.1002/mco2.307 |
work_keys_str_mv | AT dengguangtong riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT zhouqian riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT mengyu riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT sunhuiyan riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT dusongtao riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT liuyihuang riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis AT zengfurong riskandoutcomesofbreakthroughcovid19infectionsinvaccinatedimmunocompromisedpatientsametaanalysis |